Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
184.66B | 223.94B | 231.46B | 192.02B | 191.72B | Gross Profit |
22.29B | 35.61B | 38.43B | 20.70B | 20.98B | EBIT |
13.19B | 26.09B | 27.75B | 10.96B | 11.10B | EBITDA |
28.52B | 36.12B | 37.62B | 20.07B | 19.46B | Net Income Common Stockholders |
12.49B | 22.45B | 19.70B | 8.45B | 8.95B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
52.21B | 48.99B | 43.07B | 27.64B | 36.37B | Total Assets |
436.92B | 385.79B | 373.72B | 348.97B | 318.46B | Total Debt |
91.18B | 82.41B | 86.10B | 87.56B | 92.82B | Net Debt |
38.97B | 33.42B | 43.03B | 59.92B | 56.45B | Total Liabilities |
172.12B | 156.85B | 159.78B | 152.73B | 146.48B | Stockholders Equity |
255.24B | 217.55B | 203.72B | 189.24B | 165.58B |
Cash Flow | Free Cash Flow | |||
-1.12B | 16.98B | 24.66B | 4.29B | -4.72B | Operating Cash Flow |
22.03B | 29.82B | 31.42B | 20.61B | 14.97B | Investing Cash Flow |
-16.02B | -4.57B | -5.88B | -16.37B | -17.21B | Financing Cash Flow |
-5.01B | -20.52B | -10.27B | -13.12B | 12.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥216.63B | 19.49 | 1.68% | 4.22% | -10.66% | ||
76 Outperform | ¥58.58B | 10.34 | 4.28% | -2.75% | 21.09% | ||
69 Neutral | ¥212.73B | 17.47 | 3.68% | 0.46% | 1.06% | ||
67 Neutral | ¥9.79B | 8.52 | 4.33% | -0.59% | 60.77% | ||
64 Neutral | $4.25B | 11.69 | 5.23% | 249.83% | 4.04% | -9.46% |